The results of the heart transplantation operations performed personally by one surgeon (CNB) at Groote Schuur Hospital between 1967 and 1980 are reviewed. Of 9 orthotopic transplants performed between 1967 and 1973, 4 survived for more than one year and 2 remain alive today twelve and ten years later. Of 11 heterotopic transplants performed since 1974, one-year patient survival has been 82%, though one patient survived on his own heart after irreversible graft rejection. Three of the original 4 patients remain alive over five years later. These results are rather better than the overall results of our unit, where a total of 37 heterotopic transplants has been performed; the possible reasons for this are discussed. One patient, previously unreported, who underwent transplantation of the heart and both lungs in 1971, died after 23 days from pulmonary complications. Heterotopic transplantation using a xenograft (baboon or chimpanzee heart) has been performed on two occasions as a means of temporary circulatory support in patients with acutely failing hearts when no human donor was available. The chimpanzee heart supported the circulation satisfactorily for four days.
Introduction
Heart transplantation is one of the more successful forms of organ transplantation, with oneyear graft and patient survival of over 60% in established centres (Barnard et al. 1981 , Baumgartner et al. 1979 .
Human-to-human heart transplantation was first carried out in Groote Schuur Hospital, Cape Town, on 2 December 1967 (Barnard 1967) . Since that time several hundred transplants have been performed throughout the world, but only a handful of centres have followed a continuing programme. One of us (CNB) has been involved clinically since the beginning and a review of the patients operated on personally by this surgeon, in contrast to those operated on by other members of our unit, has been undertaken, and is briefly reported here.
Orthotopic heart transplantation Between December 1967 and December 1973 orthotopic heart transplantation, following the technique developed in the experimental animal (Lower & Shumway 1960) and incorporating a personal modification which reduced the risk of damage to the sinu-atrial node with resulting conduction abnormalities (Barnard 1968) , was performed in 10 patients at Groote Schuur Hospital. One of these operations was performed by another surgeon.
Those operated on personally (by CNB) included 8 men and one woman with a mean age of50 years and a range of 36 to 63 years. Seven of these 9 patients were 50 years or older with three being 55 years or more; with experience gained since that time, many of these patients would have been considered too old to undergo the rigours of transplantation with its accompanying prolonged immunosuppressive therapy.
Nevertheless, 4 patients (44%) survived for more than one year, enjoying an excellent quality of life, and 2 remain active today twelve and ten years respectively since operation (Cooper et al. 1980) . These 2 long-term survivors were the only patients under the age of 50 years at the time of operation. Survival times might well have been much longer if, as would be the case today, younger patients had been selected for transplantation.
The major cause of death in this group was infection, with neoplasia responsible for one death in a patient who had remained well for almost two years. There was one operative death, related to failure of the donor heart to support the circulation, and it was this, together with certain other considerations, which led this unit to initiate an experimental programme to develop a technique of inserting the donor heart as an accessory or auxiliary pump, leaving the recipient's own heart in situ.
Heterotopic heart transplantation
Exploration of the possibility of using the donor heart as an accessory pump had been carried out previously in the experimental animal (Cooper 1968) , most notably by the Russian surgeon Demikhov (1962) . Two new techniques were developed at the University of Cape Town (Barnard & Losman 1975) , the first being a means of bypassing or supporting the left ventricle only, and the second a means of biventricular support.
As we saw the situation then (1974), and still see it today, heterotopic heart transplantation otTers several advantages over orthotopic transplantation. The recipient tight ventricle is often normal or only slightly diseased or, in some cases oflongstanding left ventricular failure, hypertrophied in response to a raised pulmonary vascular resistance. Excision of such a ventricle would seem unnecessary and, where a raised pulmonary vascular resistance is present, throws an acute burden on the normal right ventricle, which it may be unable to meet. Even the excision of the recipient's left ventricle can be criticized on the basis that, although diseased to the extent that the cardiac output is significantly reduced, it can still maintain a systemic circulation which is compatible with a restricted life. The recipient heart may lend valuable support during the initial hours after transplantation when the donor organ may be recovering from the ischaemic period experienced during transfer, and again during periods when donor heart function is reduced from severe acute rejection. We have subsequently documented recipient heart support in these situations on many occasions. Furthermore, there is a possibility in certain forms of myocardial disease, such as myocarditis or even cardiomyopathy, that life-threatening left ventricular failure may be temporary and, if the patient's circulation can be supported by an auxiliary heart for a period of time, then recovery may occur. We have subsequently seen this in one patient who led an active life for almost four years after undoubtedly being kept alive by a functioning heterotopic transplant during a critical three months' period.
The successful development of both left ventricular bypass and biventricular bypass in the baboon led us in November 1974 to embark on a clinical programme of heterotopic heart transplantation. Although since that time we have not performed orthotopic transplantation, we believe that this operation is still indicated under certain circumstances, in particular in the presence of a prosthetic valve in the recipient heart.
Left ventricular bypass: The technique has been described previously (Barnard & Losman 1975) and involves anastomosis of the donor and recipient left atria and aortae. Donor coronary venous blood is returned via the donor pulmonary artery to the recipient right atrium.
Only two patients (both men, aged 59 and 47 years respectively) underwent this procedure: the first succumbed to a pulmonary embolus -l l l days after transplantation, and the other remains well and actively employed six and a quarter years later; this patient has been reinvestigated and reported recently (Cooper et al. 1980) . Both patients suffered recurrent attacks of recipient heart dysrhythmias including ventricular fibrillation, during which time the donor heart satisfactorily supported the circulation alone, but for this reason the technique was superseded by biventricular bypass.
Biventricular bypass: Anastomoses between the right atria, left atria, aortae and pulmonary arteries are performed, allowing blood to flow through either donor or recipient right heart and either left heart.
Between May 1975and April 1981, 35 such transplants have been performed in 33 patients, two undergoing retransplantation for rejection. Patient average age was 37 years with a range of 14 to 52 years. All but 3 of the patients were men. The one-year survival has been 64%, twoyear survival 50% and three-year survival 40%. The operations have been performed by no fewer than eight surgeons.
Those patients operated on personally (by CNB) included 9 men and one woman with a mean age of 36 (range 24 to 52 years), and included one of the retransplant operations. The retransplanted patient, who had lung disease prior to operation, developed adult respiratory distress syndrome, requiring tracheostomy, and died of pneumonia 24 days after operation. Of the others, 7 survived for more than one year (though one patient has undergone rejection and survives on his own heart awaiting retransplantation), and the most recent patient remains well four months after transplantation. The only patient to die within the first year was a 24year-old woman who arrested irreversibly on the first postoperative day, almost certainly from an accidental overdose of intravenous potassium, both hearts suddenly becoming asystolic.
Excluding the patient retransplanted, the one-year patient survival of this group is, therefore, 89%, though graft survival is 78%. Four of the 6 patients operated on more than two years ago actually survived for more than two years (67%); one patient with good graft function for over eighteen months contributed to his death towards the end of the second year by failing to take his medication regularly. Two patients remain alive over five years after transplantation.
If all the patients receiving heterotopic transplants are considered together, that is, if the two left heart bypass patients are added to the nine biventricular bypass patients (excluding the patient retransplanted), six are still alive today between four months and six and a quarter years after operation. One-year patient survival has been 82%, 8 of the II patients surviving with functioning grafts (73%), and 5 of these living more than two years (63%). Three of the original 4 patients receiving heterotopic grafts remain alive today over five (2 patients) and six (one patient) years later.
These results, in unselected patients, are rather better than the overall results of this unit. A number of factors may be involved. The postoperative management of patients undergoing heart transplantation is difficult, and the experience of the surgical team in this area must be an important factor in the long-term success or failure of the procedure. It is likely that a more personal interest is shown in the postoperative progress by the surgeon actually performing the operation; the more experienced the surgeon, then the greater the possibility of successfully avoiding or overcoming the hazards of rejection and infection.
A greater number of the early patients in this series were operated on by CNB; at that time it was the unit's policy to give 'booster' doses of steroids, for example, 1g methylprednisolone intravenously, initially weekly and subsequently at increasing intervals during the first few months following transplantation. This innovative regimen had been introduced in our unit earlier (Barnard 1969) in an attempt to prevent rejection rather than treat it once it had become manifested clinically. Though we have no confirmatory statistical evidence, it may well be that such 'pulses' of steroid were of some value in preventing rejection episodes; we have recently returned to this policy.
Transplantation of the heart and both lungs
On 25 July 1971, a 49-year-old man with chronic obstructive airways disease and bilateral basal bronchiectasis underwent orthotopic transplantation of the heart and both lungs. This patient has not been reported previously. He had been ill since 1958 with dyspnoea on exertion and a productive cough, and was diagnosed at that time as having emphysema. He had steadily deteriorated over the years until, two months before operation, he had become bedridden and reliant on continuous oxygen therapy together with antibiotics, steroids, and anti-failure medication. The patient had severely deranged respiratory function tests and blood gas analyses.
Anastomoses between the donor and recipient right atria, aortae and both bronchi were made. The bronchi rather than the trachea were chosen for the airway anastomosis as it was felt that the vascular supply at these sites would be more satisfactory, and therefore the risk of necrosis and subsequent late air leak reduced; in lung transplantation, necrosis at the anastomotic site has been found to be less frequent when the length of donor bronchus is short (Veith 1977) . Dissection at the carina, with its vascular lymph nodes, was also avoided by choosing the bronchi rather than the trachea as the site for anastomosis.
The patient initially did well, but developed an air leak at the site of the right bronchial anastomosis, which an intercostal flap procedure at a subsequent thoracotomy failed to control; a right pneumonectomy was ultimately necessary on the nineteenth postoperative day. Pneumonia, including a lung abscess, had developed in the left lung, and the patient died on the twenty-third postoperative day. Autopsy showed an infected haematoma around the heart, and bronchopneumonia of the left lung, but no significant rejection of the transplanted heart or lungs; the cause of death was considered to be a klebsiella pneumonia and septicaemia.
Integrity of the bronchial anastomosis in the immunosuppressed patient has been a major problem in the few recorded cases of lung transplantation (Veith 1977) , and it would seem likely that the bronchial (or tracheal) anastomosis will retard progress in those patients who would benefit from transplantation of the heart and lungs together. The experience gained from this patient, however, did suggest that early acute rejection of the lungs, which would seem to be the organs more likely to undergo rapid rejection, could at least be delayed by suitable immunosuppression and, that, if a bronchopleural fistula had not developed, pneumonia may not have been inevitable. Successful transplantation of the lungs, however, probably awaits more sophisticated means of immunosuppression, and it will be interesting to see whether the new drug cyclosporin A can provide this; early experimental results are encouraging (Reitz et al. 1980) .
Heterotopic heart transplantation using xenografts
One of the indications for heterotopic cardiac transplantation is toprovide temporary circulatory support, when all other measures have been unsuccessful, to a failing heart in anticipation of its subsequent recovery.
Human donors are frequently not available when required and we have used xenografts on two emergency occasions . On both occasions the patient's left ventricle failed to take over the responsibility for the circulation when attempts were made to discontinue cardiopulmonary bypass at the end of surgical procedures. Intra-aortic balloon pump support was unsuccessful in the first case and not available in the second.
The first patient received a heterotopic graft from a 30 kilogram baboon which proved insufficient to support the entire circulation in the presence of repeated attacks of ventricular fibrillation which affected the patient's own heart, the patient dying some six hours after transplantation.
The second patient, operated on 13 October 1977, was supported successfully for four days by an auxiliary chimpanzee heart until rejection of the xenograft resulted in failure of this heart, the recipient's own heart having failed to recover sufficiently to support the circulation alone. Rather higher doses of immunosuppression were used than would be the case with a human donor.
From this experience it would appear that a heterotopic transplant using a suitable xenograft and heavy immunosuppression can support a patient's circulation for at least two to three days, and may be indicated where there is evidence that the patient's own cardiac function will recover during this period. With improved methods of immunosuppression it may be that the use of xenografts will become acceptable, not only on a temporary basis, where the intra-aortic balloon pump plays a similar role, but possibly even as a permanent procedure. Such relatively rare animals as the higher primates, though possibly most suitable from an immunological standpoint, may never be readily available in large numbers, and the pig or other anatomically similar animal may ultimately prove to be the donor of choice.
The use of xenografts would undoubtedly overcome the problem of donor supply, which remains the critical limiting factor to the number of transplants performed in our unit each year. However, this and other potential developments await a solution to the problem of the immune response; the encouraging results being obtained from immunosuppression with cyclosporin A and from the induction of tolerance by total lymphoid irradiation (Myburgh et al. 1980 ) may take us a little nearer to this goal.
